CBD oil in MCT (10%)

Broad-spectrum cannabidiol produced in Switzerland
This CBD oil dissolved in MCT oil contains 10% broad-spectrum cannabidiol (1000 mg CBD) extracted from certified Swiss hemp. The product is completely THC-free and combines CBD with MCT oil, which is an easily absorbed carrier oil, ideal for cosmetic skin care. The bottle comes with a medical dropper for easy and accurate application.

Benefits and effects
CBD oil dissolved in MCT oil supplies the skin with essential fatty acids that are absorbed quickly and help keep the skin balanced and moisturised. MCT oil is known for its medium-chain triglycerides that nourish the skin, while CBD can have a soothing effect that is well suited for dry or sensitive skin.

Note: This product is intended for cosmetic use.

Ingredients and contents

• Ingredients: MCT oil, broad-spectrum CBD oil (1000 mg cannabidiol from Swiss hemp)
• Contents per bottle: 10 ml, corresponding to approx. 270 drops
• THC content: 0.0% - lab tested and confirmed THC free

Instructions for use
Shake the bottle well before use. Apply a few drops to the desired skin area morning and evening for optimal effect. For new users, it is recommended to start with a low dose to assess the skin's response. Store in a cool, dry place, protected from direct sunlight to preserve quality.

Quality control and test results
We carry out extensive testing on all our CBD products. Our CBD oil undergoes laboratory tests in Switzerland to ensure the correct cannabinoid content and microbiological safety, as well as the absence of heavy metals, pesticides and other contaminants. We use biodegradable packaging from a British partner, which supports our environmentally friendly profile and contributes to a sustainable production chain.

Reservation

Only for adults over 18 years of age. Not recommended for pregnant or lactating women without medical approval. This product is intended for cosmetic use and is not intended for oral administration. Uno Vita AS makes no medical claims about the product's effects. We always recommend consulting a healthcare professional before use if you have medical conditions or are taking prescription medications.

Freedom of expression and right to information

Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like in accordance with laws on freedom of expression. This includes:

• United Nations Universal Declaration of Human Rights (1948): Article 19
• The International Covenant on Civil and Political Rights (1966): Article 19
• Section 100 of the Norwegian Constitution
• America's First Amendment

Relevant references:

1. Huestis, M.A. (2007). Human Cannabinoid Pharmacokinetics.
2. Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids.
3. Mechoulam, R., & Parker, L.A. (2013). The endocannabinoid system and the brain.
4. Russo, E. B. (2011). Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
5. Pertwee, R.G. (2006). Cannabinoid pharmacology.
6. Pisanti, S., et al. (2017). Cannabidiol: State of the art and new challenges for therapeutic applications.
7. McPartland, J.M., et al. (2015). Cannabidiol modulation of the endocannabinoid system.
8. Zuardi, A.W. (2008). Cannabidiol: A drug with a wide spectrum of action.
9. Pamplona, ​​F.A., et al. (2018). The anti-inflammatory properties of cannabidiol.
10. Shannon, S., et al. (2019). Cannabidiol in anxiety and sleep.
11. Ashton, C.H. (2001). Effects of cannabis: A brief review.
12. Pertwee, R.G., et al. (2018). Cannabinoids in health and disease.